Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,531.00    1.00 (0.07%)
Bid:
1,531.00
Ask:
1,532.00
Spread: 1.00 (0.065%)
Market Cap: £3.22b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Hikma Pharmaceuticals News

UPDATE 3-Pandemic fears pummel European stocks into correction territory
27 Feb 2020

UPDATE 3-Pandemic fears pummel European stocks into correction territory

(For a live blog on European stocks, type LIVE/ in an Eikon news window)* Travel and leisure, basic resources stocks worst hit* WPP leads losses on S...

UPDATE 2-UK shares briefly slip into correction as coronavirus wreaks havoc
27 Feb 2020

UPDATE 2-UK shares briefly slip into correction as coronavirus wreaks havoc

* FTSE 100 down 3.5%, FTSE 250 slides 4.1%* Both indexes briefly in correction* StanChart slips after warning on virus hit* WPP slides as Q4 disappoin...

CORRECTED-UPDATE 1-Hikma sees 2020 sales growth after profit beats view on newer drugs
27 Feb 2020

CORRECTED-UPDATE 1-Hikma sees 2020 sales growth after profit beats view on newer drugs

(Corrects to say U.S. sales rose 5%, not 61%, and removes reference to double-digit growth across segments in paragraph four)* 2019 core sales and c...

UPDATE 1-Hikma sees 2020 sales growth after profit beats view on newer drugs
27 Feb 2020

UPDATE 1-Hikma sees 2020 sales growth after profit beats view on newer drugs

* 2019 core sales and core oper. profit top expectations* Sees 2020 injectables sales growth in low to mid-single digits* Currently does not see mate...

Hikma posts decent results as it signs 'Ryaltris' deal with Glenmark
27 Feb 2020

Hikma posts decent results as it signs 'Ryaltris' deal with Glenmark

(Sharecast News) - Hikma Pharmaceuticals reported a 6% improvement in group core revenue in its preliminary results on Thursday, to $2.2bn (£1.7b...

UK Earnings, Trading Statements Calendar - Next 7 Days
20 Feb 2020

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday broker round-up
20 Feb 2020

Thursday broker round-up

(Sharecast News) - Travis Perkins: Citigroup upgrades to buy with a target price of 1,900p.

Monday broker round-up
17 Feb 2020

Monday broker round-up

(Sharecast News) - Hikma Pharmatheuticals: Citigroup downgrades to neutral with a target price of 1,980p.